Registered Manager Accountability for Medicines Governance and Audit Follow-Up
Medicines governance is one of the clearest areas where Registered Manager accountability can be tested. Records may appear complete, but risks remain if stock checks, refusals, errors, storage and follow-up actions are not properly reviewed.
Strong Registered Manager accountability for medicines oversight helps services show that medicines risks are identified and acted on quickly.
This should be supported by CQC evidence and assurance for medicines governance, including MAR audits, care records, staff competency checks and feedback.
The wider CQC compliance knowledge hub for governance and inspection places medicines safety within accountable, well-led adult social care.
Why this matters
Liability risk increases when medicines concerns are recorded but not followed through. A missing signature, unexplained stock difference or repeated refusal may indicate wider risk.
CQC and commissioners expect the Registered Manager to know whether medicines systems are safe in practice. They will look beyond training records and ask how errors are prevented.
Good medicines governance links daily administration, audit, escalation, staff competence and outcomes for people.
A clear framework for medicines accountability
Effective medicines governance needs accurate records, stock control, safe storage, competency oversight and prompt investigation of exceptions.
The Registered Manager should ensure that medicines audits do not simply list errors. They must lead to action, review and evidence that risk reduced.
The audit trail should show what was found, who reviewed it, what changed and how improvement was confirmed.
Operational example 1: Unexplained stock discrepancy
Baseline issue: Stock checks showed repeated small discrepancies, but the cause was not identified. The measurable improvement target was zero unexplained discrepancies for eight weeks, evidenced through care records, audits, feedback and staff practice.
Step 1: The medication lead completes the scheduled stock count, compares recorded balance with actual stock, and records any difference in the medicines stock check log.
Step 2: The shift leader checks the MAR chart for the same period, looks for omitted entries or recording errors, and records findings in the medication exception record.
Step 3: The Registered Manager reviews the discrepancy before the next medicine cycle, decides the immediate risk level, and records the decision in the medicines governance file.
Step 4: The deputy manager observes the next medication round for the staff member involved, checks stock handling, and records findings on the competency observation form.
Step 5: The provider quality lead reviews discrepancy trends at month end, checks whether actions reduced risk, and records assurance in provider oversight minutes.
What can go wrong is that small discrepancies are treated as routine. Early warning signs include repeated corrections, unclear balances or staff uncertainty about stock recording. Escalation may introduce double-checking, competency review or temporary restriction from medicine duties. Consistency is maintained through stock trend review.
Governance audits check stock logs, MAR records, discrepancy actions and competency evidence. The Registered Manager reviews all discrepancies, with provider review monthly. Action is triggered by unexplained stock movement, repeated staff involvement, missing records or any risk to safe administration.
Operational example 2: Repeated medicine refusals without review
Baseline issue: A person repeatedly refused prescribed medicine, but staff recorded refusal without management follow-up. The measurable improvement target was same-week review after repeated refusals, evidenced through care records, audits, feedback and staff practice.
Step 1: The administering staff member records the refusal at the time of the round, notes the reason given where known, and enters it on the MAR chart.
Step 2: The senior carer checks refusal patterns during the shift review, identifies repeated refusal, and records the concern in the medicines escalation log.
Step 3: The Registered Manager reviews the repeated refusal within the same week, considers risk and consent issues, and records the decision in the care record.
Step 4: The key worker discusses the concern with the person where appropriate, explores barriers or preferences, and records the discussion in the care plan review note.
Step 5: The medication lead confirms whether professional advice is required, records any advice received, and updates the medicines action tracker.
What can go wrong is that refusal is recorded as choice without review of risk or support. Early warning signs include repeated refusal, changing presentation or family concern. Escalation may involve GP, pharmacist or nursing advice. Consistency is maintained through refusal trigger checks.
Governance audits check MAR refusal entries, escalation logs, care plan updates and professional advice. The Registered Manager reviews repeated refusals weekly. Action is triggered by repeated refusal, deterioration, unclear consent, missing advice or no recorded follow-up.
Operational example 3: Medicine storage temperature not acted on
Baseline issue: Temperature records showed occasional out-of-range readings, but corrective action was inconsistent. The measurable improvement target was 100% recorded action for out-of-range readings, evidenced through audits, care records, feedback and staff practice.
Step 1: The allocated staff member records the medicine storage temperature at the scheduled check, notes any out-of-range reading, and enters it in the storage monitoring log.
Step 2: The shift leader reviews the out-of-range reading immediately, checks whether medicines may be affected, and records the initial action in the medicines safety log.
Step 3: The Registered Manager decides whether pharmacy advice is needed, confirms the action route, and records the decision in the medicines governance record.
Step 4: The administrator contacts the pharmacy where instructed, records the advice received, and saves the response in the medicines advice folder.
Step 5: The deputy manager checks storage records weekly, confirms that out-of-range readings have action notes, and records findings in the medicines audit tracker.
What can go wrong is that temperature checks are completed but not interpreted. Early warning signs include missing action notes, repeated equipment concerns or unclear pharmacy advice. Escalation may remove affected medicines from use until advice is confirmed. Consistency is maintained through weekly storage audit.
Governance audits check temperature logs, action records, pharmacy advice and equipment checks. The deputy reviews weekly, with Registered Manager review monthly. Action is triggered by out-of-range readings, missing action notes, repeated storage issues or uncertainty about medicine safety.
Commissioner expectation
Commissioners expect medicines systems to protect people from avoidable harm. They may ask how the Registered Manager identifies medicines risk and confirms that corrective action is completed.
They will look for evidence that medicines issues are not repeatedly found without improvement. This includes audit trails, staff competence and professional advice where needed.
Strong medicines governance reassures commissioners that quality concerns are acted on before they become safeguarding or contract performance issues.
Regulator and inspector expectation
CQC inspectors may review MAR charts, stock records, storage logs, care plans and staff explanations. They will expect medicines governance to be consistent and current.
If records show repeated discrepancies, refusals or storage issues without action, inspectors may question whether the service is safe and well-led.
The Registered Manager should evidence audits, investigation notes, staff competency checks, professional advice and measurable improvement.
Conclusion
Registered Manager accountability for medicines governance depends on active oversight. Medicines records must be checked, interpreted and followed by timely action where risk is identified.
Outcomes are evidenced through MAR charts, care records, stock checks, storage logs, audits, feedback and staff practice. Improvement is shown when discrepancies reduce, refusals are reviewed and storage issues have clear action records.
Consistency is maintained through scheduled audits, clear escalation triggers, competency checks and provider oversight. The Registered Manager must know where medicines risk exists and whether agreed controls are working.
For CQC and commissioners, this demonstrates that medicines governance is not passive record keeping. It is a live safety system that protects people and reduces liability through evidence, review and measurable improvement.